{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-037399","form_type":"8-K","ticker":"BMNM","cik":"0001275477","company_name":"BIMINI CAPITAL MANAGEMENT, INC.","filed_at":"2025-12-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.014283+00:00","generated_at":"2026-05-16T13:37:26.635940+00:00","sec_items":["1.01","3.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Bimini Capital extends poison pill to 2030, raises purchase price to $10.20 to protect NOLs","bullets":["Rights plan expiration extended five years to December 21, 2030.","Purchase price per right increased from $4.76 to $10.20.","Aims to protect ~$253.9M in net operating loss carryforwards under Section 382.","Amendment subject to stockholder approval at 2026 annual meeting; terminates if not approved by June 30, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-037399","json":"https://secwatch.observer/filing/0001437749-25-037399.json","markdown":"https://secwatch.observer/filing/0001437749-25-037399.md","text":"https://secwatch.observer/filing/0001437749-25-037399.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1275477/000143774925037399/0001437749-25-037399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1275477/000143774925037399/bcmi20251208_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:37:26.635940+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9f01db9f12e2206b9ec6f6ad2c1fabdc11163d31","claim":"BIMINI CAPITAL MANAGEMENT, INC. issued unit.","evidence_excerpt":"The First Amendment extends the expiration date of the Rights (as defined in the Rights Agreement) until December 21, 2030. The First Amendment also increases the Purchase Price (as defined in the Rights Agreement) from $4.76 to $10.20.","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1275477/000143774925037399/0001437749-25-037399-index.htm","confidence":0.9,"family_label":"Equity Issuances","details":[{"label":"Security","value":"unit"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}